References
- 1. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol. 2013;168:934-945.
- 2. Lauer MS. Advancing cardiovascular research. Chest. 2012;141:500-505.
- 3. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98-102.
- 4. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008;451:937-942.
- 5. Asahara T, Kalka C, Isner JM. Stem cell therapy and gene transfer for regeneration. Gene therapy. 2000;7:451-457.
- 6. Borlongan CV, Glover LE, Tajiri N, Kaneko Y, Freeman TB. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders. Progress in neurobiology. 2011;95:213-228.
- 7. Tendera M, Wojakowski W, Ruzyllo W, et al. Intracoronary infusion of bone marrow-derived selected CD34+ CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced ventricular ejection fraction: results of randomized, multicenter Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J. 2009;30:1313-1321.
- 8. Meyer GP, Wollert CK, Lotz J, et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5 year follow-up from the randomized-controlled BOOST trial. Eur Heart J. 2009;30:2978-2984.
- 9. Benedek I, Bucur O, Benedek T. Intracoronary Infusion of Mononuclear Bone Marrow-Derived Stem Cells is Associated with a Lower Plaque Burden After Four Years. J Atheroscle Thromb. 2013;21:216-229.
- 10. Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol. 2010;7:204-215.
- 11. Lau JF, Anderson SA, Adler E, Frank JA. Imaging approaches for the study of cell-based cardiac therapies. Nat Rev Cardiol. 2010;7:97-105.
- 12. Beeres SL, Bengel FM, Bartunek J, et al. Role of imaging in cardiac stem cell therapy. J Am Coll Cardiol. 2007;49:1137-1148.
- 13. Amado LC, Saliaris AP, Schuleri KH, et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005;102:11474-1179.
- 14. Sayyed SH, Cassidy MM, Hadi MA. Use of multidetector computed tomography for evaluation of global and regional left ventricular function. J Cardiovasc Comput Tomogr. 2009;3:23-34.
- 15. Assmus B, Honold J, Schächinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006;355:1222-1232.
- 16. Nyolczas N, Gyöngyösi M, Beran G, et al. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of non-selected autologous bone marrow cells to patients after acute myocardial infarction. Am Heart J. 2007;153:212.e1-e7.
- 17. Voros S. What are the potential advantages and disadvantages of volumetric CT scanning? J Cardiovasc Comput Tomogr. 2009;3:67-70.
- 18. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324-2336.
- 19. Voros S, Rinehart S, Qian Z, et al. Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. JACC Cardiovasc Imaging. 2011;4:537-548.
- 20. Boogers MJ, Broersen A, van Velzen JE, et al. Automated quantification of coronary plaque with computed tomography: comparison with intravascular ultrasound using a dedicated registration algorithm for fusion-based quantification. Eur Heart J. 2012;33:1007-1016.
- 21. Budoff MJ, Shaw LJ, Liu ST, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol. 2007;49:1860-1870.
- 22. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;291:210-215.
- 23. Arbab-Zadeh A, Fuster V. The Myth of the “Vulnerable Plaque”: transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol. 2015;65:846-855.
- 24. de Graaf MA, Broersen A, Kitslaar PH, et al. Automatic quantification and characterization of coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with intravascular ultrasound virtual histology. Int J Cardiovasc Imaging. 2013;29:1177-1190.
- 25. de Feyter PJ, Nieman K. CCTA to guide revascularization for high-risk CAD: a “cliff hanger”. Eur Heart J. 2012;33:3011-3013.
- 26. Schuleri KH, Centola M, Choi SH, et al. CT for Evaluation of Myocardial Cell Therapy in Heart Failure. JACC Cardiovasc Imaging. 2011;4:1284-1293.
- 27. Schuleri KH, Feigenbaum GS, Centola M, et al. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J. 2009;30:2722-2732.
- 28. Quevedo HC, Hatzistergos KE, Oskouei BN, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A. 2009;106:14022-14027.
- 29. Amado LC, Schuleri KH, Saliaris AP, et al. Multimodality Noninvasive Imaging Demonstrates In Vivo Cardiac Regeneration After Mesenchymal Stem Cell Therapy. J Am Coll Cardiol. 2006;48:2116-2124.
- 30. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.